Scientific Evidences & Presentations

Trifocal performance excellent far, near & intermediate vision
1. Fernandez J. et al. – published in Curr. Eye Res 2018
2. García-Bella J. et al. – published in Eur. J. Ophthalmol. 2018
3. Fernandez J. et al. - WOC 2018 presentation
4. Gyory J. - ESCRS 2017 presentation
Outstanding contrast sensitivity especially in mesopic condition
1. Van Acker E. – ESCRS 2017 presentation
2. Gyory J. - ESCRS 2017 presentation
Complete spectacle independence
1. Dexl A.K. - ESCRS 2015 presentation
2. Van Acker E. – ESCRS 2017 presentation
High patient satisfaction
1. Gyory J. - ESCRS 2017 presentation
2. Dunai A. et al. – ESCRS 2017 presentation
Minimal reports of dysphotopsia
1. García-Bella J. et al. – published in Eur J Ophthalmol. 2018
2. Hernandez- Meijide N. et al. – ASCRS 2018 presentation
Refractive predictability
1. Fernandez J. et al. - WOC 2018 presentation
2. Fernandez J. et al. - ESCRS 2017 presentation

References

“

“The most balanced trifocal IOL on the market.”

M. Assouline, MD, PhD(France)
“

“Clinical evidence of prospective randomized study catapulted Liberty into high quality trifocal group of IOLs available on the market.”

E. Van Acker, MD(Belgium)
“

“After over 100 implantations trifocal performance is evident. Less halos & glare, better contrast sensitivity. All my patients implanted with Liberty are spectacle independent.”

J. Győri, MD(Hungary)
CONTACT US